CYTOKINETICS, INCORPORATED Revenues
CYTOKINETICS, INCORPORATED (CYTK) reported Revenues of $10.64 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2018-11-09
- CYTOKINETICS, INCORPORATED revenues for the quarter ending 2018-09-30 was $10.64M, a 72.18% increase year-over-year.
- CYTOKINETICS, INCORPORATED revenues for the quarter ending 2018-06-30 was $6.21M, a 103.57% increase year-over-year.
- CYTOKINETICS, INCORPORATED revenues for the quarter ending 2018-03-31 was $5.27M, a 26.85% increase year-over-year.
- CYTOKINETICS, INCORPORATED revenues for the quarter ending 2017-12-31 was -$18.00K, a 100.05% decline year-over-year.
- CYTOKINETICS, INCORPORATED revenues for fiscal 2017 was $13.37M, a 87.44% decline from fiscal 2016.
- CYTOKINETICS, INCORPORATED revenues for fiscal 2016 was $106.41M, a 271.30% increase from fiscal 2015.
- CYTOKINETICS, INCORPORATED revenues for fiscal 2015 was $28.66M, a 38.95% decline from fiscal 2014.
- CYTOKINETICS, INCORPORATED revenues for fiscal 2014 was $46.94M, a 53.16% increase from fiscal 2013.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month | Revenues 167 month | Revenues 170 month | Revenues 173 month | Revenues 176 month | Revenues 179 month | Revenues 182 month | Revenues 185 month | Revenues 188 month | Revenues 191 month | Revenues 194 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $10.64M 10-Q · filed 2018-11-09 | $16.86M derived: sum of 2 quarters · filed 2018-11-09 | $22.12M 10-Q · filed 2018-11-09 | $22.11M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2018-06-30 | $6.21M 10-Q · filed 2018-08-07 | $11.48M 10-Q · filed 2018-08-07 | $11.46M derived: sum of 3 quarters · filed 2018-08-07 | $17.64M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2018-03-31 | $5.27M 10-Q · filed 2018-05-10 | $5.25M derived: sum of 2 quarters · filed 2018-05-10 | $11.43M derived: sum of 3 quarters · filed 2018-11-09 | $14.48M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2017-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $6.16M derived: sum of 2 quarters · filed 2018-11-09 | $9.21M derived: sum of 3 quarters · filed 2018-11-09 | $13.37M 10-K · filed 2018-03-05 | ||||||||||
| 2017-09-30 | $6.18M 10-Q · filed 2018-11-09 | $9.23M derived: sum of 2 quarters · filed 2018-11-09 | $13.39M 10-Q · filed 2018-11-09 | $46.52M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||
| 2017-06-30 | $3.05M 10-Q · filed 2018-08-07 | $7.21M 10-Q · filed 2018-08-07 | $40.34M derived: sum of 3 quarters · filed 2018-08-07 | $99.39M derived: sum of 4 quarters · filed 2018-08-07 | ||||||||||
| 2017-03-31 | $4.15M 10-Q · filed 2018-05-10 | $37.29M derived: sum of 2 quarters · filed 2018-05-10 | $96.34M derived: sum of 3 quarters · filed 2018-05-10 | $102.14M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||||
| 2016-12-31 | $33.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $92.19M derived: sum of 2 quarters · filed 2018-03-05 | $97.99M derived: sum of 3 quarters · filed 2018-03-05 | $106.41M 10-K · filed 2018-03-05 | ||||||||||
| 2016-09-30 | $59.05M 10-Q · filed 2017-11-03 | $64.85M derived: sum of 2 quarters · filed 2017-11-03 | $73.27M 10-Q · filed 2017-11-03 | $83.03M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-06-30 | $5.80M 10-Q · filed 2017-08-04 | $14.22M 10-Q · filed 2017-08-04 | $23.98M derived: sum of 3 quarters · filed 2018-03-05 | $31.93M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2016-03-31 | $8.42M 10-Q · filed 2017-05-04 | $18.18M derived: sum of 2 quarters · filed 2018-03-05 | $26.12M derived: sum of 3 quarters · filed 2018-03-05 | $32.66M derived: sum of 4 quarters · filed 2018-03-05 | ||||||||||
| 2015-12-31 | $9.76M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-05 | $17.70M derived: sum of 2 quarters · filed 2018-03-05 | $24.24M derived: sum of 3 quarters · filed 2018-03-05 | $28.66M 10-K · filed 2018-03-05 | ||||||||||
| 2015-09-30 | $7.95M 10-Q/A · filed 2016-12-15 | $14.49M derived: sum of 2 quarters · filed 2016-12-15 | $18.90M 10-Q/A · filed 2016-12-15 | $40.66M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2015-06-30 | $6.54M 10-Q · filed 2016-08-04 | $10.96M 10-Q · filed 2016-08-04 | $32.71M derived: sum of 3 quarters · filed 2017-03-06 | $42.13M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2015-03-31 | $4.41M 10-Q · filed 2016-05-05 | $26.17M derived: sum of 2 quarters · filed 2017-03-06 | $35.59M derived: sum of 3 quarters · filed 2017-03-06 | $43.38M derived: sum of 4 quarters · filed 2017-03-06 | ||||||||||
| 2014-12-31 | $21.76M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $31.17M derived: sum of 2 quarters · filed 2017-03-06 | $38.96M derived: sum of 3 quarters · filed 2017-03-06 | $46.94M 10-K · filed 2017-03-06 | ||||||||||
| 2014-09-30 | $9.41M 10-Q · filed 2015-11-05 | $17.20M derived: sum of 2 quarters · filed 2015-11-05 | $25.18M 10-Q · filed 2015-11-05 | $49.53M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-06-30 | $7.79M 10-Q · filed 2015-08-05 | $15.77M 10-Q · filed 2015-08-05 | $40.12M derived: sum of 3 quarters · filed 2016-03-03 | $44.59M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2014-03-31 | $7.98M 10-Q · filed 2015-05-04 | $32.33M derived: sum of 2 quarters · filed 2016-03-03 | $36.80M derived: sum of 3 quarters · filed 2016-03-03 | $37.81M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||
| 2013-12-31 | $24.35M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $28.82M derived: sum of 2 quarters · filed 2016-03-03 | $29.83M derived: sum of 3 quarters · filed 2016-03-03 | $30.65M 10-K · filed 2016-03-03 | ||||||||||
| 2013-09-30 | $4.47M 10-Q · filed 2014-11-06 | $5.48M derived: sum of 2 quarters · filed 2014-11-06 | $6.30M 10-Q · filed 2014-11-06 | $8.48M derived: sum of 4 quarters · filed 2015-03-06 | $183.93M 10-Q · filed 2013-11-06 | |||||||||
| 2013-06-30 | $1.01M 10-Q · filed 2014-08-07 | $1.83M 10-Q · filed 2014-08-07 | $4.01M derived: sum of 3 quarters · filed 2015-03-06 | $5.73M derived: sum of 4 quarters · filed 2015-03-06 | $179.47M 10-Q · filed 2013-08-07 | |||||||||
| 2013-03-31 | $821.00K 10-Q · filed 2014-05-07 | $3.00M derived: sum of 2 quarters · filed 2015-03-06 | $4.72M derived: sum of 3 quarters · filed 2015-03-06 | $6.56M derived: sum of 4 quarters · filed 2015-03-06 | $178.46M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-06 | $3.90M derived: sum of 2 quarters · filed 2015-03-06 | $5.74M derived: sum of 3 quarters · filed 2015-03-06 | $7.56M 10-K · filed 2015-03-06 | $177.63M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $1.71M 10-Q · filed 2013-11-06 | $3.56M derived: sum of 2 quarters · filed 2013-11-06 | $5.38M 10-Q · filed 2013-11-06 | $6.13M derived: sum of 4 quarters · filed 2014-03-07 | $175.45M 10-Q · filed 2012-11-07 | |||||||||
| 2012-06-30 | $1.84M 10-Q · filed 2013-08-07 | $3.66M 10-Q · filed 2013-08-07 | $4.42M derived: sum of 3 quarters · filed 2014-03-07 | $5.84M derived: sum of 4 quarters · filed 2014-03-07 | $173.74M 10-Q · filed 2012-08-06 | |||||||||
| 2012-03-31 | $1.82M 10-Q · filed 2013-05-08 | $2.58M derived: sum of 2 quarters · filed 2014-03-07 | $4.00M derived: sum of 3 quarters · filed 2014-03-07 | $5.06M derived: sum of 4 quarters · filed 2014-03-07 | $171.90M 10-Q · filed 2012-05-04 | |||||||||
| 2011-12-31 | $757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $2.18M derived: sum of 2 quarters · filed 2014-03-07 | $3.24M derived: sum of 3 quarters · filed 2014-03-07 | $4.00M 10-K · filed 2014-03-07 | $170.08M 10-K · filed 2012-03-13 | |||||||||
| 2011-09-30 | $1.43M 10-Q · filed 2012-11-07 | $2.48M derived: sum of 2 quarters · filed 2012-11-07 | $3.24M 10-Q · filed 2012-11-07 | $4.34M derived: sum of 4 quarters · filed 2013-03-15 | $169.32M 10-Q · filed 2011-11-04 | |||||||||
| 2011-06-30 | $1.05M 10-Q · filed 2012-08-06 | $1.82M 10-Q · filed 2012-08-06 | $2.92M derived: sum of 3 quarters · filed 2013-03-15 | $3.31M derived: sum of 4 quarters · filed 2013-03-15 | $167.89M 10-Q · filed 2011-08-04 | |||||||||
| 2011-03-31 | $763.00K 10-Q · filed 2012-05-04 | $1.86M derived: sum of 2 quarters · filed 2013-03-15 | $2.26M derived: sum of 3 quarters · filed 2013-03-15 | $2.72M derived: sum of 4 quarters · filed 2013-03-15 | ||||||||||
| 2010-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $1.49M derived: sum of 2 quarters · filed 2013-03-15 | $1.96M derived: sum of 3 quarters · filed 2013-03-15 | $2.58M 10-K · filed 2013-03-15 | ||||||||||
| 2010-09-30 | $394.00K 10-Q · filed 2011-11-04 | $856.00K derived: sum of 2 quarters · filed 2011-11-04 | $1.48M 10-Q · filed 2011-11-04 | |||||||||||
| 2010-06-30 | $462.00K 10-Q · filed 2011-08-04 | $1.08M 10-Q · filed 2011-08-04 | ||||||||||||
| 2009-12-31 | $81.54M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |